Icon Limited
Icon Limited, a leading global provider in the clinical research industry, is headquartered in Great Britain. Founded in 1990, the company has established itself as a key player in the development of innovative solutions for the pharmaceutical, biotechnology, and medical device sectors. With a strong presence across Europe, North America, and Asia, Icon Limited offers a comprehensive range of services, including clinical trial management, data analytics, and regulatory consulting. What sets Icon Limited apart is its commitment to leveraging advanced technology and deep industry expertise to enhance trial efficiency and patient engagement. The company has achieved significant milestones, including numerous successful drug approvals and partnerships with top-tier clients. Recognised for its excellence, Icon Limited continues to solidify its market position as a trusted partner in the pursuit of medical advancements.
DitchCarbon Score
How does Icon Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Icon Limited's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Icon Limited, headquartered in Great Britain, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company is a current subsidiary and may inherit emissions data from its parent organization, but no specific details or figures have been provided. In terms of climate commitments, Icon Limited has not outlined any reduction targets or initiatives, nor does it appear to participate in recognised frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). This lack of publicly available information suggests that the company may still be in the early stages of developing its climate strategy. As a subsidiary, it is important to note that any potential climate commitments or emissions data may be influenced by the policies and practices of its parent company. However, without specific data or commitments from Icon Limited itself, it is challenging to provide a comprehensive overview of its carbon emissions and climate initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | - | 000,000,000 | 000,000,000 |
| Scope 2 | - | 000,000 | 000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Icon Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
